To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.
Also called NCT05508438
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 140 participants
- Sponsor
- Pan Xiangbin
- Registry
-
NCT05508438
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT05508438. Allocation not applicable; no masking; primary purpose treatment. Start 2022-08-30 (anticipated); primary completion 2023-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment
- Condition
- Mitral Valve Insufficiency
- Intervention (Device)
- Transfemoral mitral-valve repair
- Lead sponsor
- Pan Xiangbin
Record details
- Record id
cardio:ct-nct05508438- Content hash
e5b2a5609aaaa5533fd72d9a889e6f92410ff538f1b3ed132ffa9ad2c31765ee